Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07461441 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy

Study acronym: HANGANG
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To evaluate the Efficacy of a personalized treat-and-extend regimen of faricimab for treatment-naive polypoidal choroidal vasculopathy
Trial Details
NCT Number NCT07461441
Lead Sponsor Yeungnam University College of Medicine
Conditions
(from sponsor)		 Polypoidal Choroidal Vasculopathy (PCV), Age Related Macular Degeneration
Related terms Macular Degeneration, Polypoidal Choroidal Vasculopathy
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov